Search research articles
Contact Us
Filters
Showing results (91-100 of 332) with videos related to
Page
of 34
Sort By:
Biochimica Et Biophysica Acta
|
November 29, 2005
Kinetic analysis of the inhibition of human butyrylcholinesterase with cymserine
Mohammad A Kamal, Abdulaziz A Al-Jafari, Qian-Sheng Yu, et al.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
|
January 31, 2013
Molecular interaction study of N1-p-fluorobenzyl-cymserine with TNF-α , p38 kinase and JNK kinase
Sidra Batool, Muhammad Sulaman Nawaz, Nigel H Greig, et al.
Nature Reviews. Drug Discovery
|
December 24, 2013
A new roadmap for drug development for Alzheimer's disease
Robert E Becker, Nigel H Greig, Ezio Giacobini, et al.
Neuromolecular Medicine
|
July 14, 2007
Differential effects of two hexahydropyrroloindole carbamate-based anticholinesterase drugs on the amyloid beta protein pathway involved in Alzheimer's disease
Debomoy K Lahiri, George M Alley, David Tweedie, et al.
Journal of Neurochemistry
|
April 9, 2010
Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells
Yazhou Li, David Tweedie, Mark P Mattson, et al.
Nutritional Neuroscience
|
July 18, 2025
Targeting protein kinases in Parkinson's disease: the emerging role of phytoconstituents
Disha Joshi, Mangesh Kulkarni, Pathik Parekh, et al.
Journal of Neurochemistry
|
January 11, 2007
Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity
Joachim Hartmann, Cornelia Kiewert, Ellen G Duysen, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
November 18, 2020
Age-related impairment of cerebral blood flow response to K<sub>ATP</sub> channel opener in Alzheimer's disease mice with presenilin-1 mutation
Dong Liu, Ismayil Ahmet, Brandon Griess, et al.
The Biochemical Journal
|
August 30, 2008
Accommodation of physostigmine and its analogues by acetylcholinesterase is dominated by hydrophobic interactions
Dov Barak, Arie Ordentlich, Dana Stein, et al.
Ageing Research Reviews
|
May 18, 2024
Type 2 diabetes mellitus/obesity drugs: A neurodegenerative disorders savior or a bridge too far?
Katherine O Kopp, Elliot J Glotfelty, Yazhou Li, et al.
Page
of 34
Search research articles
Search
Showing results (91-100 of 332) with videos related to
Sort By:
Page
of 34
Biochimica Et Biophysica Acta
|
November 29, 2005
Kinetic analysis of the inhibition of human butyrylcholinesterase with cymserine
Mohammad A Kamal, Abdulaziz A Al-Jafari, Qian-Sheng Yu, et al.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
|
January 31, 2013
Molecular interaction study of N1-p-fluorobenzyl-cymserine with TNF-α , p38 kinase and JNK kinase
Sidra Batool, Muhammad Sulaman Nawaz, Nigel H Greig, et al.
Nature Reviews. Drug Discovery
|
December 24, 2013
A new roadmap for drug development for Alzheimer's disease
Robert E Becker, Nigel H Greig, Ezio Giacobini, et al.
Neuromolecular Medicine
|
July 14, 2007
Differential effects of two hexahydropyrroloindole carbamate-based anticholinesterase drugs on the amyloid beta protein pathway involved in Alzheimer's disease
Debomoy K Lahiri, George M Alley, David Tweedie, et al.
Journal of Neurochemistry
|
April 9, 2010
Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells
Yazhou Li, David Tweedie, Mark P Mattson, et al.
Nutritional Neuroscience
|
July 18, 2025
Targeting protein kinases in Parkinson's disease: the emerging role of phytoconstituents
Disha Joshi, Mangesh Kulkarni, Pathik Parekh, et al.
Journal of Neurochemistry
|
January 11, 2007
Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity
Joachim Hartmann, Cornelia Kiewert, Ellen G Duysen, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
November 18, 2020
Age-related impairment of cerebral blood flow response to K<sub>ATP</sub> channel opener in Alzheimer's disease mice with presenilin-1 mutation
Dong Liu, Ismayil Ahmet, Brandon Griess, et al.
The Biochemical Journal
|
August 30, 2008
Accommodation of physostigmine and its analogues by acetylcholinesterase is dominated by hydrophobic interactions
Dov Barak, Arie Ordentlich, Dana Stein, et al.
Ageing Research Reviews
|
May 18, 2024
Type 2 diabetes mellitus/obesity drugs: A neurodegenerative disorders savior or a bridge too far?
Katherine O Kopp, Elliot J Glotfelty, Yazhou Li, et al.
Page
of 34